This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Dec 2025

Ketorolac-BFS Ketorolac tromethamine 30mg

Ketorolac Trometamol 30 mg/ml solution for injection is indicated for the short-term management of moderate to severe acute post-operative pain. Treatment should only be initiated in hospitals. The maximum duration of treatment is two days.

CompositionKetorolac tromethamine 30mg

Dosage Form
Solution for injection

Indication
Ketorolac Trometamol 30 mg/ml solution for injection is indicated for the short-term management of moderate to severe acute post-operative pain. Treatment should only be initiated in hospitals. The maximum duration of treatment is two days.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile